-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Abeona Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Abeona Therapeutics Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$15.3M, a 35.4% decline year-over-year.
- Abeona Therapeutics Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$60.7M, a 29.6% decline year-over-year.
- Abeona Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$47.1M, a 7.42% increase from 2022.
- Abeona Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$50.9M, a 43.3% increase from 2021.
- Abeona Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$89.8M, a 10.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)